Andrew Bellinger
2022
In 2022, Andrew Bellinger earned a total compensation of $3.3M as Chief Scientific Officer and Chief Medical Officer at Verve Therapeutics, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,280 |
|---|---|
| Option Awards | $2,615,650 |
| Salary | $476,100 |
| Other | $12,468 |
| Total | $3,319,498 |
Bellinger received $2.6M in option awards, accounting for 79% of the total pay in 2022.
Bellinger also received $215.3K in non-equity incentive plan, $476.1K in salary and $12.5K in other compensation.
Rankings
In 2022, Andrew Bellinger's compensation ranked 1,087th out of 5,717 executives tracked by ExecPay. In other words, Bellinger earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,087 out of 5,717 | 81st |
Division Manufacturing | 515 out of 3,111 | 83rd |
Major group Chemicals And Allied Products | 184 out of 1,410 | 87th |
Industry group Drugs | 165 out of 1,311 | 87th |
Industry Pharmaceutical Preparations | 123 out of 957 | 87th |
Source: SEC filing on April 28, 2023.
Bellinger's colleagues
We found two more compensation records of executives who worked with Andrew Bellinger at Verve Therapeutics in 2022.